SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001178913-24-002107
Filing Date
2024-07-01
Accepted
2024-07-01 06:47:48
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A zk2431622.htm SC 13D/A 61725
  Complete submission text file 0001178913-24-002107.txt   63090
Mailing Address 2155 PARK BOULEVARD PALO ALTO CA 94306
Business Address 2155 PARK BOULEVARD PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Subject) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87931 | Film No.: 241088125
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 6 HACHOSHLIM ST. HERZELIA L3 4672406
Business Address
Arkin Moshe (Filed by) CIK: 0001321178 (see all company filings)

Type: SC 13D/A